AIMS: The aim of this study was to examine the level of and predictors of statin nonadherence and discontinuation among older adults. METHODS: Among 22 340 Australians aged ≥65 years who initiated statin therapy from January 2014 to December 2015, we estimated the first-year nonadherence (proportion of days covered [PDC] <0.80) and discontinuation (≥90 days without statin coverage) rates. Predictors of nonadherence and discontinuation were examined via multivariable logistic regression. Analyses were performed separately for general beneficiaries (with a higher co-payment; n = 4841) and concessional beneficiaries (with a lower co-payment; n = 17 499). RESULTS: During the one-year follow-up, 55.1% were nonadherent (concessional 52.6%; genera...
Purpose: Study drug discontinuation is commonplace in clinical trials of older populations. Little i...
BACKGROUND: Optimal management of chronic medications for patients with life-limiting illness is unc...
Introduction: Risk thresholds for using statins to prevent cardiovascular disease (CVD) have recentl...
Aims: The aim of this study was to examine the level of and predictors of statin nonadherence and di...
Background: Older individuals (aged ≥65 years) are commonly prescribed statins but may experience a ...
BackgroundThe discontinuation of statin medication is associated with an increased risk of cardiovas...
OBJECTIVES: To estimate rates of discontinuation and restarting of statins, and to identify patient ...
BACKGROUND: Statins reduce the risk of cardiovascular disease in patients with diabetes. This study ...
Objectives: To estimate rates of discontinuation and restarting of statins, and to identify patient...
BACKGROUND: The discontinuation of statin medication is associated with an increased risk of cardiov...
Objectives: Previous Australian research has shown that following the 21% increase in patient co-pay...
Background: Statins comprise a key strategy for the prevention and treatment of arteriosclerotic car...
Background The discontinuation of statin medication is associated with an increased risk of cardiov...
Importance: Polypharmacy is a major health concern among older adults. While deprescribing may reduc...
International audienceAIMS: The role of statin therapy in primary prevention of cardiovascular disea...
Purpose: Study drug discontinuation is commonplace in clinical trials of older populations. Little i...
BACKGROUND: Optimal management of chronic medications for patients with life-limiting illness is unc...
Introduction: Risk thresholds for using statins to prevent cardiovascular disease (CVD) have recentl...
Aims: The aim of this study was to examine the level of and predictors of statin nonadherence and di...
Background: Older individuals (aged ≥65 years) are commonly prescribed statins but may experience a ...
BackgroundThe discontinuation of statin medication is associated with an increased risk of cardiovas...
OBJECTIVES: To estimate rates of discontinuation and restarting of statins, and to identify patient ...
BACKGROUND: Statins reduce the risk of cardiovascular disease in patients with diabetes. This study ...
Objectives: To estimate rates of discontinuation and restarting of statins, and to identify patient...
BACKGROUND: The discontinuation of statin medication is associated with an increased risk of cardiov...
Objectives: Previous Australian research has shown that following the 21% increase in patient co-pay...
Background: Statins comprise a key strategy for the prevention and treatment of arteriosclerotic car...
Background The discontinuation of statin medication is associated with an increased risk of cardiov...
Importance: Polypharmacy is a major health concern among older adults. While deprescribing may reduc...
International audienceAIMS: The role of statin therapy in primary prevention of cardiovascular disea...
Purpose: Study drug discontinuation is commonplace in clinical trials of older populations. Little i...
BACKGROUND: Optimal management of chronic medications for patients with life-limiting illness is unc...
Introduction: Risk thresholds for using statins to prevent cardiovascular disease (CVD) have recentl...